Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11469 posts found.

AbbVie to enter deal with HotSpot for up to $335m

December 7, 2022 Sales and Marketing

AbbVie and HotSpot Therapeutics have begun working on a licensing option deal for HotSpot’s preclinical small-molecule allosteric therapy, which will …
News

EMA accepts marketing authorisation application for ALS treatment, tofersen

December 7, 2022 Sales and Marketing

The European Medicines Agency (EMA) has accepted a marketing authorisation application (MAA) for tofersen. The drug would treat superoxide dismutase …
News

AstraZeneca to acquire Neogene for up to $320m

November 29, 2022 Sales and Marketing

AstraZeneca has announced that it is planning to buy Neogene for up to $320m. Biotechnology group Neogene has a focus …
News

Full-Life Technologies to acquire Focus-X Therapeutics

November 29, 2022 Sales and Marketing

Full-Life Technologies, a fully integrated global radiotherapeutics company, has announced that they have agreed to acquire US-based Focus-X Therapeutics.  
News

Siemens Healthineers and Atrium Health team up in $140m deal

November 29, 2022 Sales and Marketing

Atrium Health, a US-based non-profit health provider, has signed a partnership with Siemens Healthineers to buy $140m worth of healthcare …
News

C4X Discovery signs licensing deal worth up to $402m with AstraZeneca

November 28, 2022 Sales and Marketing

Pioneering drug discovery company, C4X Discovery Holdings (C4XD) has signed a licensing agreement with AstraZeneca, worth up to $402m. The …
News

Novo Nordisk suffers profit loss over obesity drug as manufacturing problems continue

November 23, 2022 Sales and Marketing

Danish pharma company Novo Nordisk, has reported a 2% loss in their third quarter sales report, compared to the previous …
News

Haemophilia drug costing $3.5m per dose has been approved

November 23, 2022 Sales and Marketing

CSL Behring’s haemophilia B gene therapy has recently been approved by US regulators, however the treatment has an enormous price …
News

Approval of only twice-yearly HIV treatment option

August 22, 2022 Sales and Marketing

The European Commission (EC) has granted a Marketing Authorisation for Sunlenca (lenacapavir) injection and tablets for the treatment of HIV …
News

NICE issues positive appraisal document for combination treatment for advanced kidney cancer

August 22, 2022 Sales and Marketing

NICE has published an appraisal consultation document (ACD) recommending the use of lenvatinib as a therapeutic option for untreated intermediate …
News

EMA accept marketing authorisation application for invasive candidiasis treatment

August 22, 2022 Sales and Marketing

The EMA has accepted the marketing authorisation application (MAA) for rezafungin, for the treatment of invasive candidiasis in adult patients. …
News

New WHO recommendations for Ebola treatments and improved access

August 22, 2022 Sales and Marketing

WHO has published its first guideline for Ebola virus disease therapeutics, calling on the global community to increase access to …
News

Sanofi and NIHR enrol first patient in immunisation study for RSV in infants

August 15, 2022 Sales and Marketing

The European study will evaluate the use of the human recombinant monoclonal antibody nirsevimab   Sanofi and the National Institute …
News

NHS England outlines measures to boost capacity ahead of substantial winter pressures

August 15, 2022 Sales and Marketing

The package of measures includes creating the equivalent of 7,000 additional hospital beds   NHS England has announced a package …
News
blood_brain

Focused ultrasound therapies could be made more affordable by 3D-printed acoustic holograms to help overcome the blood-brain barrier

August 15, 2022 Sales and Marketing

The 3D-printed acoustic hologram is used with focused ultrasound (FUS) to create a more controlled and precise opening in the …
News

Latest content

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024